查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1775457

全球假藥檢測設備市場：2025-2030 年預測

Global Counterfeit Drug Detection Device Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

假藥檢測設備市場預計將從 2025 年的 17.42 億美元成長到 2030 年的 22.93 億美元，複合年成長率為 5.65%。

假藥帶來的公共衛生風險

假藥對全球公共衛生構成嚴重威脅，導致疾病和死亡，尤其是在中低收入國家。世界衛生組織 (WHO) 估計，假藥約佔全球醫藥市場的 10%，有些地區的報告比例甚至超過 30%。然而，澳洲、加拿大和許多歐盟國家都擁有嚴格的監管制度，將假藥的普及率控制在 1% 以下。電子商務的興起加劇了這個問題，約 50% 的假藥是透過隱藏地址的非法網站出售的。這種日益嚴重的威脅，加上弱勢群體缺乏意識，正在推動對先進檢測設備的需求，以確保藥品真實性並保護患者安全。

法規和產業舉措

嚴格的監管以及政府和醫療機構日益增強的意識正在推動市場成長。美國食品藥物管理局)預計在 2023 年查獲價值 40 億美元的假藥，凸顯了對強大檢測解決方案的需求。全球監管機構正在執行更嚴格的品管標準，並鼓勵採用先進技術打擊假藥販運。製藥公司也因假藥面臨巨大的財務損失和聲譽風險，因此增加了對檢測設備的投資，以保護其供應鏈。

技術進步

光譜學和攜帶式設備

技術創新是市場成長的前沿，而光譜設備正是其驅動力。 2023年3月，Invita Healthcare Technologies推出了PharmaDefense，這是一款致力於假藥檢測的開創性解決方案，可增強快速現場檢驗。賽默飛世爾科技的可攜式XRF分析儀、NIR和拉曼光譜儀符合現行良好生產規範(GMP)和21 CFR Part 11標準，可在30秒內現場識別和量化藥物成分。這些儀器提供快速、無損的分析，最大限度地減少對耗時的實驗室檢測的依賴，並確保高品質的檢驗以打擊假藥。

人工智慧和高階成像

人工智慧 (AI) 與先進成像技術的融合正在徹底改變假冒仿冒品的檢測方式。 2023 年 12 月，Nynomic AG 收購了 Art Photonics GmbH，以增強其光纖偵測能力。人工智慧解決方案，例如在韓國國家資訊技術產業振興院的支持下於 2021 年 12 月推出的 Stratio, Inc.影像處理技術，提高了邊境檢查站的準確性。此外，Spectral Engines 於 2023 年發布的 NIRONE® 掃描儀，將近紅外線 (NIR) 技術與雲端連接和先進演算法相結合，為材料分析和假藥檢測提供了承包解決方案。

RFID和區塊鏈

無線射頻識別 (RFID) 和區塊鏈技術正日益獲得支持，以提升供應鏈透明度。 2024 年，受要求原料藥使用QR碼和 RFID 標籤的法規推動，製藥業將擴大採用 RFID 來追蹤假藥。由 Hyperledger Fabric 提供支援的雲端基礎區塊鏈框架能夠安全且透明地追蹤藥品，並透過序列化包裝和智慧合約降低假冒風險。

市場區隔分析

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 研究範圍
  • 市場區隔

第3章 商業景氣

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

5. 假藥檢測設備市場（按模式）

  • 介紹
  • 行動裝置
  • 手持裝置
  • 桌上型裝置

6. 假藥檢測設備市場（依產品類型）

  • 介紹
  • RFID分析儀
  • 掃描和成像系統
  • 色譜法
  • 光譜儀
  • 光譜儀

7. 假藥檢測設備市場（依技術）

  • 介紹
  • 紅外線和近紅外光譜
  • 微流體（桌上型和手持設備）
  • 快速化學檢測
  • 拉曼光譜
  • RFID技術
  • 其他

第8章 假藥檢測設備市場（依最終用戶）

  • 介紹
  • 製藥公司
  • 藥物檢測實驗室
  • 研究機構

9. 假藥檢測設備市場（按地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 台灣
    • 泰國
    • 其他

第10章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第11章 公司簡介

  • Bayer AG
  • Thermo Fisher Scientific Inc.
  • Spectral Engines Oy
  • GAO Group
  • Systech International
  • Advanced Systems Development, Inc.
  • B&W Tek
  • Centice Corporation
  • Consumer Physics
  • Global Pharma HealthCare Ltd.

第12章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061613498

The Global Counterfeit Drug Detection Device Market is expected to grow from USD 1.742 billion in 2025 to USD 2.293 billion in 2030, at a CAGR of 5.65%.

Public Health Risks from Counterfeit Drugs

Counterfeit drugs pose a severe threat to global public health, contributing to illnesses and deaths, particularly in low- and middle-income countries. The World Health Organization estimates that counterfeit drugs account for approximately 10% of the global pharmaceutical market, with some regions exceeding 30%. In contrast, stringent regulatory systems in countries like Australia, Canada, and many EU nations limit counterfeit prevalence to less than 1%. The rise of e-commerce, with around 50% of counterfeit drugs sold through illegal websites with hidden addresses, exacerbates the issue. This growing threat, combined with a lack of awareness in vulnerable populations, drives demand for advanced detection devices to ensure drug authenticity and protect patient safety.

Regulatory and Industry Initiatives

Stringent regulations and heightened awareness among governments and healthcare organizations are fueling market growth. In 2023, the U.S. Food and Drug Administration seized over $4 billion worth of counterfeit pharmaceuticals, highlighting the need for robust detection solutions. Globally, regulatory bodies are enforcing stricter quality control standards, encouraging the adoption of advanced technologies to combat counterfeit drug trafficking. Pharmaceutical companies also face significant financial losses and reputational risks from counterfeit drugs, prompting increased investment in detection devices to safeguard supply chains.

Technological Advancements

Spectroscopy and Portable Devices

Technological innovations are at the forefront of market growth, with spectroscopy-based devices leading the charge. In March 2023, InVita Healthcare Technologies launched Pharma Defense, a pioneering solution focused on counterfeit drug detection, enhancing rapid on-site verification. Thermo Fisher Scientific's portable XRF Analyzer, NIR, and Raman Spectrometers enable on-site identification and quantification of pharmaceutical ingredients within 30 seconds, adhering to current good manufacturing practices and 21 CFR Part 11 standards. These devices provide fast, non-destructive analysis, minimizing reliance on time-consuming laboratory tests and ensuring high-quality verification to combat counterfeit drugs.

AI and Advanced Imaging

The integration of artificial intelligence (AI) and advanced imaging techniques is transforming counterfeit detection. In December 2023, Nynomic AG acquired Art Photonics GmbH, enhancing its fiber optic-based detection capabilities. AI-powered solutions, such as Stratio, Inc.'s imaging technology launched in December 2021 with support from South Korea's National IT Industry Promotion Agency, improve accuracy at border checkpoints. Additionally, Spectral Engines' NIRONE(R) Scanner, introduced in 2023, combines NIR technology with cloud connectivity and advanced algorithms, offering a turnkey solution for material analysis and fake drug detection.

RFID and Blockchain

Radio-frequency identification (RFID) and blockchain technologies are gaining traction for supply chain transparency. In 2024, the pharmaceutical industry increasingly adopted RFID to track falsified drugs, driven by regulatory mandates for QR codes and RFID tags on active pharmaceutical ingredients. Cloud-based blockchain frameworks, utilizing Hyperledger Fabric, enable secure, transparent tracking of pharmaceutical products, reducing counterfeit risks through serialized packaging and smart contracts.

Market Segmentation Analysis

Spectroscopy Segment

The spectroscopy segment, including Raman and near-infrared (NIR) technologies, held a significant market share in 2024, valued at USD 0.96 billion. Its non-destructive nature and rapid results make it ideal for on-site verification in pharmacies, border controls, and manufacturing facilities. The segment's growth is driven by demand for portable, user-friendly devices.

Portable Devices

Portable counterfeit detection devices, such as handheld scanners, are gaining popularity due to their flexibility and ease of use in field settings. These devices, including Thermo Fisher's TruScan Raman and microPHAZIR RX NIR analyzers, support rapid screening, enhancing accessibility and adoption across diverse end-users, including regulatory authorities and distributors.

Regional Insights

North America dominates the market, holding a 34.2% revenue share projected by 2037, driven by stringent regulations, advanced healthcare infrastructure, and high counterfeit drug awareness. The region's market was valued at USD 1.0 billion in 2024. The Asia-Pacific region is the fastest-growing, fueled by rising counterfeit drug prevalence, government initiatives, and local manufacturing of detection devices. China, with a 22% increase in fake drugs reported in 2023, is prioritizing advanced detection technologies. Europe follows, with a market size of USD 0.7 billion in 2024, supported by robust regulatory frameworks.

Market Challenges

High costs of advanced detection devices and limited awareness in developing regions pose challenges. Additionally, the sophistication of counterfeit drugs requires continuous technological upgrades, straining R&D budgets. Regulatory gaps in emerging markets further complicate enforcement efforts.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Modality

  • Portable Devices
  • Hand-Held Devices
  • Bench-Top Devices

By Product Type

  • RFID Analyzer
  • Scanning and Imaging Systems
  • Chromatographs
  • Spectrometers
  • Spectroscopes

By Technology

  • Infrared and Near-Infrared Spectroscopy
  • Microfluidic (Benchtop and Handheld Devices)
  • Rapid Chemical Testing
  • Raman Spectroscopy
  • RFID Technology
  • Other

By End User

  • Pharmaceutical Companies
  • Drug Testing Laboratories
  • Research Organizations

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Others
  • Middle East and Africa
  • UAE
  • Israel
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY MODALITY

  • 5.1. Introduction
  • 5.2. Portable Devices
  • 5.3. Hand-Held Devices
  • 5.4. Bench-Top Devices

6. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY PRODUCT TYPE

  • 6.1. Introduction
  • 6.2. RFID Analyzer
  • 6.3. Scanning and Imaging Systems
  • 6.4. Chromatographs
  • 6.5. Spectrometers
  • 6.6. Spectroscopes

7. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY TECHNOLOGY

  • 7.1. Introduction
  • 7.2. Infrared and Near-Infrared Spectroscopy
  • 7.3. Microfluidic (Benchtop and Handheld Devices)
  • 7.4. Rapid Chemical Testing
  • 7.5. Raman Spectroscopy
  • 7.6. RFID Technology
  • 7.7. Other

8. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Pharmaceutical Companies
  • 8.3. Drug Testing Laboratories
  • 8.4. Research Organizations

9. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. Taiwan
    • 9.6.5. Thailand
    • 9.6.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Bayer AG
  • 11.2.Thermo Fisher Scientific Inc.
  • 11.3.Spectral Engines Oy
  • 11.4.GAO Group
  • 11.5.Systech International
  • 11.6.Advanced Systems Development, Inc.
  • 11.7.B&W Tek
  • 11.8.Centice Corporation
  • 11.9.Consumer Physics
  • 11.10.Global Pharma HealthCare Ltd.

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations